Assessment

Addiction Medicine New Patient Assessment Template

A full first-visit assessment for patients presenting with substance use concerns, covering use history by substance, withdrawal risk, medical and psychiatric comorbidity, and a treatment plan the patient has agreed to.

Template

Assessment template

Addiction Medicine New Patient Assessment

Referral and Presentation

Referral source: [Self, family physician, emergency department, inpatient team, court or employer. Include the referral question]

Reason for visit: [Patient’s stated reason for seeking care today, in their own words where possible]

Patient goals: [Abstinence, reduced use, safer use, managing withdrawal, starting medication. Record what matters most to the patient]

Substance Use History

SubstanceAge first useCurrent pattern (amount, frequency)RouteLast useLongest abstinence
Alcohol[ ][Standard drinks per day or week][ ][Date and time][ ]
Opioids[ ][Type: fentanyl, heroin, prescription][ ][ ][ ]
Stimulants[ ][Methamphetamine, cocaine, prescription][ ][ ][ ]
Cannabis[ ][ ][ ][ ][ ]
Benzodiazepines / sedatives[ ][Prescribed or non-prescribed][ ][ ][ ]
Tobacco / nicotine[ ][ ][ ][ ][ ]
Other[ ][ ][ ][ ][ ]

[Delete rows for substances the patient denies, or mark "Denies"]

Consequences of use: [Health, relationships, work, legal, housing and financial consequences discussed. Omit if not discussed]

DSM-5 criteria met: [Number of criteria met per substance and resulting severity: mild, moderate or severe]

Withdrawal and Overdose Risk

Withdrawal history: [Prior withdrawal symptoms, seizures, delirium tremens, hospital admissions for withdrawal]

Current withdrawal: [Current symptoms and timing. Include scale scores if done, e.g. COWS [ ] or CIWA-Ar [ ]]

Overdose history: [Number of prior overdoses, most recent date, whether naloxone was used]

Risk factors: [Using alone, fentanyl exposure, recent abstinence or incarceration, mixing sedatives]

Treatment History

Prior treatment: [Withdrawal management, residential programs, counseling, mutual support groups, with dates and outcomes]

Prior medications: [Buprenorphine, methadone, slow-release oral morphine, naltrexone, acamprosate, others. Doses reached, duration and reason stopped]

Medical and Psychiatric History

Medical history: [Liver disease, hepatitis B or C, HIV, endocarditis, skin and soft tissue infections, chronic pain, pregnancy status]

Psychiatric history: [Depression, anxiety, PTSD, ADHD, psychosis, prior admissions. Screening scores if done, e.g. PHQ-9 [ ]/27, GAD-7 [ ]/21]

Suicide and self-harm risk: [Current ideation, intent, plan, prior attempts and protective factors]

Medications: [Current prescribed medications including controlled substances. Note prescription monitoring program review]

Allergies: [Drug allergies with reaction, or “No known allergies”]

Social History

Housing: [Stable, unstable, unhoused, shelter]

Supports: [Family, partner, friends, peer supports. Note whether supports use substances]

Employment, income and legal: [Work, income source, current charges or court involvement. Omit if not discussed]

Dependents and driving: [Children in care, safety concerns, driving or safety-sensitive work]

Examination and Investigations

Vital signs: BP [ ] · HR [ ] · RR [ ] · Temp [ ] · SpO₂ [ ] · Weight [ ]

Examination: [General appearance, intoxication or withdrawal signs, pupils, injection sites, skin, liver stigmata, cardiac murmurs]

Mental status: [Appearance, behavior, mood, affect, thought form and content, perception, cognition, insight and judgment]

Investigations: [Urine drug screen results, liver panel, CBC, hepatitis and HIV serology, ECG (QTc if relevant), pregnancy test]

Assessment

  1. [Substance use disorder diagnosis with severity, e.g. opioid use disorder, severe] — [supporting history]
  2. [Withdrawal status and risk]
  3. [Comorbid medical or psychiatric conditions relevant to the plan]

Plan

  • Pharmacotherapy: [Medication chosen, starting dose, induction plan, dispensing arrangement. Omit if none started]
  • Withdrawal management: [Outpatient, home-based or inpatient setting and rationale]
  • Harm reduction: [Naloxone kit offered or dispensed, safer-use supplies, drug-checking, not using alone]
  • Psychosocial: [Counseling, peer support, case management or residential program referral]
  • Investigations and screening: [Labs ordered, vaccinations offered: hepatitis A and B]
  • Safety: [Driving advice, risks of combining sedatives, safety plan if risk identified]
  • Consent and education: [Risks and benefits of treatment discussed and patient’s understanding]

Follow-up: [Next visit date, interval for urine drug testing, who to contact between visits]

Text in [square brackets] is guidance for whoever (or whatever) fills the template in. Remove sections that don't apply rather than writing "N/A".

Related templates

Assessment

Substance Use Assessment

A structured screening and assessment of alcohol and drug use for counselors, social workers and clinicians, ending in a level-of-care recommendation and next steps.

Addiction Medicine +3 more

Note

Addiction Medicine Follow-up Note

A focused return-visit note for patients on addiction treatment, tracking use since last visit, medication response, urine drug testing and harm reduction in one quick-to-scan record.

Addiction Medicine +1 more

Summary

Substance Use Treatment Discharge Summary

Closes an episode of substance use treatment by summarizing what was provided, progress on goals, status at discharge and the aftercare plan, so the next provider can pick up without gaps.

Addiction Medicine +2 more

Assessment

Adverse Childhood Experiences (ACEs) Screening Note

A trauma-informed note for recording an ACEs screen: how it was offered, the total score, current symptoms and protective factors, and a plan built around support rather than a label.

Psychiatry +3 more

Notes that write themselves

Notatio listens to the visit and drafts the note in the template you choose, so you finish charting before the next patient walks in.